1. Medtech Insight
  2. >>Archive

News Briefs: PillCam Colon Clearance; CGM For Pediatrics; SGR Reform Bill

Given Imaging, soon to be part of Covidien, gained clearance for PillCam Colon capsule endoscopy device. FDA approves its first continuous glucose monitoring system for kids. Congress makes progress in the sustainable growth rate formula bill. More news.

FDA granted de novo clearance to Given Imaging Ltd.’s PillCam Colon device for the detection of colon polyps in patients for whom a complete evaluation via optical colonoscopy was not technically possible, the firm announced Feb. 3. It is a win for Medtronic Minimally Invasive Therapies, which announced its plans to buy Given for $860 million in December. (See Also see "Covidien Ventures Into Capsule-Based Endoscopy With Given Imaging Acquisition" - Medtech Insight, 16 December, 2013..) The PillCam device is a disposable capsule containing a miniaturized video camera that is swallowed by the patient, enabling physicians to view the GI tract without the need to sedate the patient. The technology is already FDA-cleared for small-bowel and esophageal imaging, but the colon indication is a bigger opportunity. The approved diagnostic indication is more restrictive than the screening indication originally sought by Given, but analysts believe Covidien’s clinical and regulatory heft could accelerate expanded labeling for the product. (See Also see "Given Imaging’s PillCam Colon 2 Strategy Shift Will Delay Screening Claim" - Medtech Insight, 20 August, 2012..)

“Overall, the colon market could be three times larger ... than small bowel, but significantly broader indications are needed,” Morgan Stanley analysts said in a Feb. 3 research note. “While...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By Ryan Nelson

Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

 
• By Ryan Nelson

Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.

Patients With Movement Disorders Will Benefit From Medtronic’s Expanded MRI Labeling For DBS

 
• By Marion Webb

Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.

Podcast: Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic

 
• By Natasha Barrow

In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.

More from Medtech Insight

Get Ready For International Harmonization Before Approaching QMSR Deadline, Says Regulatory Expert

 
• By Brian Bossetta

During MD&M East last week, regulatory consultant Darren Reeves reminded device manufacturers that the time to get ready to comply with the new Quality Management System Regulation is now.

Handheld Diagnostics: A Resurging Category That is Here to Stay

 
• By Barnaby Pickering

Handheld diagnostics are more powerful, accessible and clinically relevant than ever. Medtech Insight spoke to companies behind such technologies to learn how they work and discuss their commercial models.

Execs On The Move: 12-23 May 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.